Table A4;
Marginal FOI and the 95% confidence bounds for the age- and time-dependent marginal annual FOI by study site, previous infection status and use of AL, and by age group for children born in the baseline year (2001)
| Infection status at the previous visit and past use of AL | Age in years | Nagongera | Kihihi | Walukuba |
|---|---|---|---|---|
| Marginal annual FOI (95% CI) × 1000 | Marginal annual FOI (95% CI) × 1000 | Marginal annual FOI (95% CI) × 1000 | ||
| Lower bound | ||||
| Negative and no AL in the past | <1 | 143·78 (141·16–146·39) | 9·27 (8·52–10·01) | 10·20 (9·75–10·65) |
| 1–4 | 53·69 (53·20–54·19) | 22·69 (22·34–23·04) | 0·95 (0·92–0·97) | |
| 5–10 | 8·57 (8·53–8·62) | 7·24 (7·17–7·31) | 0·09 (0·09–0·09) | |
| Negative and AL in the past | <1 | 137·35 (134·84–139·87) | 7·64 (7·28–8·00) | 10·72 (10·27–11·18) |
| 1–4 | 51·67 (51·19–52·14) | 20·09 (19·82–20·35) | 0·99 (0·97–1·02) | |
| 5–10 | 8·29 (8·24–8·33) | 6·59 (6·52–6·65) | 0·10 (0·09–0·10) | |
| Symptomatic | <1 | 105·62 (103·73–107·51) | 6·26 (5·98–6·54) | 9·58 (9·18–9·98) |
| 1–4 | 41·4 (41·02–41·79) | 16·91 (16·70–17·12) | 0·89 (0·87–0·91) | |
| 5–10 | 6·83 (6·79–6·87) | 5·70 (5·65–5·75) | 0·09 (0·08–0·09) | |
| Asymptomatic | <1 | 426·73 (420·32–433·14) | 24·87 (23·68–26·06) | 22·88 (22·14–23·63) |
| 1–4 | 123·3 (122·22–124·39) | 55·20 (54·57–55·81) | 2·11 (2·07–2·14) | |
| 5–10 | 16·86 (16·78–16·93) | 15·69 (15·57–55·83) | 0·20 (0·20–0·20) |